Navigation Links
Strategic Analysis of Indian Biosimilar Market
Date:8/24/2011

NEW YORK, Aug. 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Strategic Analysis of Indian Biosimilar Market

http://www.reportlinker.com/p0605595/Strategic-Analysis-of-Indian-Biosimilar-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical

Table of Contents

Research Objective and Methodology 8

Executive Summary 9-10

Global Biosimilar Market 12

Introduction to Biosimilars

Global Population Demographics

Key Biodrugs

Types of Products manufactured by Major Participants

Market Size of Biosimilars: Global

Biologics Patents expiring in 2011-2016

Biologics Patents expiring in 2016-2019

Worldwide sales of Key Biodrugs

Opportunities in Market

Global Market Forecast

Major Participants: Global

Trends within global market

Indian Biosimilar Market 28

Overview of Indian Biosimilar Market

Timeline of Market

Biosimilar Value Chain in India

Indian Market Portfolio

Domestic Market Potential-Observed Trends in Market

Trends in Biosimilars moving ahead: Drivers, Restraints and Challenges

Market Drivers Ranked in order of impact

General Factors Favoring the Market

Market Restraints Ranked in order of impact

Key Restraints Summary

Hurdles faced by Indian participants

Observed Trends in Market

Export Potential -Overview

Expansion Strategy of Indian players

Highly Regulated Markets:

Europe

United States

Semi-regulated Markets:

China

Cost Advantage of India

Indian Market Forecast: 2010-2015

Regulatory Scenario 57-62

Indian regulations for Biosimilars

International Regulatory Authorities

European Medicines Agency (EMA)

US-FDA (Food and Drug Administration)

Major participants in Indian Market 64-71

Biocon

Dr. Reddy's

Ranbaxy

Wockhardt

Intas Pharmaceuticals

Shantha Biotechnics

Historical Trends and Future Impacts 70-72

2001-2010: A Historical View of the Biosimilars market

2010-2015: Frost & Sullivan View on the Biosimilars Market

Chinese Biosimilar Market 73-76

Chinese Biosimilar Market Overview

Major Players

About Frost & Sullivan 77-81

List of Figures

Biosimilar Market: Revenue of drugs nearing patent expiry (World), 2011-2019 21-22

Biosimilar Market: Revenue Forecasts (World), 2010-2015 25

Biosimilar Market: Market Portfolio (India), 2010 32-33

Biosimilar Market: Market Drivers Ranked in Order of Impact (India), 2010-2015 36-38

Biosimilar Market: Market Restraints Ranked in Order of Impact (India), 2010-2015 41-42

Biosimilar Market: Revenue Forecasts (India), 2010-2015 56

List of Charts

Biosimilar Market: Revenues of key Biodrugs whose patents expire between 2011-2019 (World), 2009 23

Biosimilar Market: Revenue Forecasts (World), 2010-2015 25

Biosimilar Market: Market Share Analysis Company-wise (World), 2009 26

Biosimilar Market: Market Share Analysis Product-wise (India), 2009 34

Biosimilar Market: Revenue Forecasts (India), 2010-2015 56

To order this report:

Biopharmaceutical Industry: Strategic Analysis of Indian Biosimilar Market

Biopharmaceutical Business News

More  Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Axial Biotech appoints new Vice President of Strategic Initiatives
2. GlaxoSmithKline and Cellzome Announce Major Strategic Alliance
3. MonoSol Rx Granted Strategic US Patent for Thin Film Manufacturing Process
4. Alfacell Hires Advisors to Advance Strategic Alternatives
5. TorreyPines Therapeutics Strategically Repositions as Development Company Focusing on Three Versatile Lead Compounds
6. CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
7. PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases
8. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
9. AMDL, Inc. Announces Strategic Realignment
10. GeneNews appoints Patrick Terry as lead strategic advisor for U.S. commercialization of ColonSentry(TM)
11. American Red Cross Expands Agreement for Strategic Blood Management(TM) Services from Strategic Healthcare Group LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... -- Cousins Properties (NYSE: CUZ ) announced today ... signed a 10-year, approximately 125,000 square-foot lease at Corporate Center, ... the Westshore submarket of Tampa, FL. ... Corporate Center for their new location in Tampa ... executive officer of Cousins Properties. "Amgen is a cutting-edge global ...
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture Fund (MBVF), ... the standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 is ... ) and the US National Institutes of Health. ... ... ...
(Date:3/27/2017)... , March 27, 2017  Perthera,s Chief Bioinformatics Officer ... Subha Madhavan , Ph.D., will be speaking at ... Panels. On Monday, March 27, 2017, she will be ... More Usable for Research and Care" (from 10:30 a.m. ... 2017, she will be a participant in the "Making ...
(Date:3/27/2017)... ... ... PMG Research is pleased to announce its participation in the 2nd ... Boston on April 3-4, 2017. The CTC conference focuses on how the industry is ... closer to the patient. Clinical Trial Collaborations also will present an inaugural conference on ...
Breaking Biology Technology:
(Date:2/14/2017)... WINSTON-SALEM, N.C. , Feb. 14, 2017  Wake ... FRY-shlog), M.D., as its new chief executive officer (CEO). ... succeeds CEO John D. McConnell , M.D., who ... new position at the Medical Center, after leading it ... oversee the full scope of Wake Forest Baptist,s academic ...
(Date:2/13/2017)... -- Former 9/11 Commission border counsel and Special Counsel ... of Identity Strategy Partners, LLP, today releases the ... Order: Protecting the Nation From Foreign Terrorist Entry Into ... President Trump,s ,Travel Ban, Executive Order gains more notoriety ... travel ban, it is important that our national discourse ...
(Date:2/9/2017)... 2017 The biomass boiler market report by ... boiler market globally in terms of revenue (US$ Mn) ... market for biomass boilers has been segmented on the ... country/region. The market based on feedstock type, has been ... & energy crops, urban residues, and others. On the ...
Breaking Biology News(10 mins):